Updated: November 15, 2020 10:44 PM
Created: November 15, 2020 10:37 PM
The world finally got some promising news about the fight against COVID-19 this past week with the announcement that Pfizer's vaccine appears to be 90% effective at stopping the coronavirus.
That huge development overshadowed another breakthrough for treating the illness: the Food and Drug Administration's emergency use authorization of bamlanivimab, a monoclonal antibody therapy.
In this week's edition of "Inside Your Health," KSTP Medical Expert Dr. Archelle Georgiou breaks down why this antibody treatment could prove to be a big step in reducing the severity of COVID-19 infections.
Copyright 2020 - KSTP-TV, LLC A Hubbard Broadcasting Company